Gastric bypass for obesity: Mechanisms of weight loss and diabetes resolution

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 6, 2004, Pages 2608-2615

  Cummings, David E ^a   Overduin, Joost ^a   Foster Schubert, Karen E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; PROTEIN DERIVATIVE;

BODY WEIGHT; CONFERENCE PAPER; CORRELATION ANALYSIS; DIABETES MELLITUS; ENERGY BALANCE; EPIDEMIC; HOMEOSTASIS; HUMAN; MALABSORPTION; OBESITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STOMACH BYPASS; STOMACH SECRETION; WEIGHT REDUCTION;

DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; GASTRIC BYPASS; HUMANS; OBESITY; WEIGHT LOSS;

EID: 2942689978     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0433     Document Type: Conference Paper

References (99)

1. Cummings DE, Schwartz MW 2003 Genetics and pathophysiology of human obesity. Annu Rev Med 54:453-471
2. Yanovski SZ, Yanovski JA 2002 Obesity. N Engl J Med 346:591-602
3. Bray GA, Tartaglia LA 2000 Medicinal strategies in the treatment of obesity. Nature 404:672-677
4. McTigue KM, Harris R, Hemphill B, Lux L, Sutton S, Bunton AJ, Lohr KN 2003 Screening and interventions for obesity in adults: summary of the evidence for the US Prevention Services Task Force. Ann Intern Med 139:933-949
5. Safer DJ 1991 Diet, behavior modification, and exercise: a review of obesity treatments from a long-term perspective. Southern Med J 84:1470-1474
6. Kopelman PG 2000 Obesity as a medical problem. Nature 404:635-643
7. Brolin RE 2002 Bariatric surgery and long-term control of morbid obesity. JAMA 288:2793-2796
8. Mun EC, Blackburn GL, Matthews JB 2001 Current status of medical and surgical therapy for obesity. Gastroenterology 120:669-681
9. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM 1995 Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339-352
10. Jones Jr KB 2000 Experience with the Roux-en-Y gastric bypass, and commentary on current trends. Obes Surg 10:183-185
11. Hafner RJ, Watts JM, Rogers J 1991 Quality of life after gastric bypass for morbid obesity. Int J Obes 15:555-560
12. Herpertz S, Keilmann R, Wolf AM, Langkafel M, Senf W, Hebebrand J 2003 Does obesity surgery improve psychosocial functioning? A systematic review. Int J Obes Relat Metab Disord 27:1300-1314
13. Fang J 2003 The cost-effectiveness of bariatric surgery. Am J Gastroenterol 98:2097-2098
14. Clegg A, Colquitt J, Sidhu M, Royle P, Walker A 2003 Clinical and cost effectiveness of surgery for morbid obesity: a systematic evaluation. Int J Obes Relat Metab Disord 27:1167-1177
15. NIH Consensus Development Panel 1991 Gastrointestinal surgery for severe obesity. Ann Intern Med 115:956-961
16. Pories WJ 2004 Diabetes: the evolution of a new paradigm. Ann Surg 239:12-13
17. Payne JH, DeWind LT 1969 Surgical treatment of obesity. Am J Surg 118: 141-147
18. Pace WG, Martin EW, Tetrick T, Fabri PJ, Carey LC 1979 Gastric partitioning for morbid obesity. Ann Surg 190:392-400
19. Mason EE 1982 Vertical banded gastroplasty for obesity. Arch Surg 117:701-706
20. Balsiger BM, Poggio JL, Mai J, Kelly KA, Sarr MG 2000 Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg 4:598-605
21. Nightengale ML, Sarr MG, Kelly KA, Jensen MD, Zinsmeister AR, Palumbo PJ 1991 Prospective evaluation of vertical banded gastroplasty as the primary operation for morbid obesity. Mayo Clin Proc 67:304-305
22. Howard L, Malone M, Michalek A, Carter J, Alger S, Van Woert J 1995 Gastric bypass and vertical banded gastroplasty - a prospective randomized comparison and 5-year follow-up. Obes Surg 5:55-60
23. Sugerman HJ, Starkey J, Birkenhauer R 1987 A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 205:613-624
24. Naslund I 1986 A prospective randomized comparison of gastric bypass and gastroplasty. Acta Chir Scand 152:681-689
25. Cummings DE, Shannon MH 2003 Roles for ghrelin in the regulation of appetite and body weight. Arch Surg 138:389-396
26. Bo O, Modalsli O 1983 Gastric banding, a surgical method of treating morbid obesity: preliminary report. Int J Obes 7:493-499
27. Kuzmak L 1992 Stoma adjustable silicone gastric banding. Prob Gen Surg 9:298-317
28. Mason EE 1969 Gastric bypass. Ann Surg 170:329-339
29. MacDonald Jr KG, Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, Pories WJ 1997 The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1:213-220
30. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH 1999 The disease burden associated with overweight and obesity. JAMA 282:1523-1529
31. Trostler N, Mann A, Zilberbush N, Avinoach E, Charuzi II 1995 Weight loss and food intake 18 months following vertical banded gastroplasty or gastric bypass for severe obesity. Obes Surg 5:39-51
32. Halmi KA, Mason E, Falk JR, Stunkard A 1981 Appetitive behavior after gastric bypass for obesity. Int J Obes 5:457-464
33. Kenler HA, Brolin RE, Cody RP 1990 Changes in eating behavior after horizontal gastroplasty and Roux-en-Y gastric bypass. Am J Clin Nutr 52:87-92
34. Sugerman HJ 1993 Morbid obesity. In: Greenfield LJ, ed. Surgery: scientific principles and practice. Philadelphia: J. B. Lippincott; 702-708
35. Faraj M, Jones P, Sniderman AD, Cianflone K 2001 Enhanced dietary fat clearance in postobese women. J Lipid Res 42:571-580
36. MacLean LD, Rhode BM, Nohr CW 2001 Long- or short-limb gastric bypass? J Gastrointest Surg 5:525-530
37. Naslund I 1987 Gastric bypass versus gastroplasty: a prospective study of differences in two surgical procedures for morbid obesity. Acta Chir Scand Suppl 536:1-60
38. Griffen Jr WO, Young VL, Stevenson CC 1977 A prospective comparison of gastric and jejunoileal bypass for morbid obesity. Ann Surg 186:500-509
39. Mason EE, Printen KJ, Blommers TJ, Scott DH 1978 Gastric bypass for obesity after ten years experience. Int J Obes 2:197-206
40. Rand CS, Macgregor AM, Hankins GC 1987 Eating behavior after gastric bypass surgery for obesity. South Med J 80:961-964
41. Hickey MS, Pories WJ, MacDonald Jr KG, Cory KA, Dohm GL, Swanson MS, Israel RG, Barakat HA, Considine RV, Caro JF, Houmard JA 1998 A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 227:637-643; discussion 643-644
42. Stoeckli R, Chanda R, Langer I, Keller U 2004 Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res 12:346-350
43. Kellum JM, Kuemmerle JF, O'Dorisio TM, Rayford P, Martin D, Engle K, Wolf L, Sugerman HJ 1990 Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg 211:763-770
44. Pappas TN 1992 Physiological satiety implications of gastrointestinal anti-obesity surgery. Am J Clin Nutr 55:571S-572S
45. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ 2002 Human plasma ghrelin levels after diet-induced weight loss and gastric bypass surgery. N Engl J Med 346:1623-1630
46. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
47. Tschop M, Smiley DL, Heiman ML 2000 Ghrelin induces adiposity in rodents. Nature 407:908-913
48. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S 2001 A role for ghrelin in the central regulation of feeding. Nature 409:194-198
49. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR 2000 The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141:4325-4328
50. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS 2001 A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719
51. Cummings DE, Frayo RS, Marmonier C, Aubert R, Chapelot D, Plasma ghrelin levels and hunger scores among humans initiating meals voluntarily in the absence of time- and food-related cues. Am J Physiol Endocrinol Metab, in press
52. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, Suda M, Koh T, Natsui K, Toyooka S, Shirakami G, Usui T, Shimatsu A, Doi K, Hosoda H, Kojima M, Kangawa K, Nakao K 2001 Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86:4753-4758
53. Geloneze B, Tambascia MA, Pilla VF, Geloneze SR, Repetto EM, Pareja JC 2003 Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes Surg 13:17-22
54. Fruhbeck G, Caballero AD, Gil MJ 2004 Fundus functionality and ghrelin concentrations after bariatric surgery. N Engl J Med 350:308-309
55. Couce M, Cottam D, Esplen J, Teijeiro R, Schauer PR, Burguera B 2003 Central vs. peripheral ghrelin: impact on human obesity. NAASO annual meeting. Obes Res 11(Suppl):A35
56. Tritos NA, Mun E, Bertkau A, Grayson R, Maratos-Flier E, Goldfine A 2003 Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res 11:919-924
57. Leonetti F, Silecchia G, Iacobellis G, Ribaudo MC, Zappaterreno A, Tiberti C, Iannucci CV, Perrotta N, Bacci V, Basso MS, Basso N, Di Mario U 2003 Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J Clin Endocrinol Metab 88:4227-4231
58. Faraj M, Havel PJ, Phelis S, Blank D, Sniderman AD, Cianflone K 2003 Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88:1594-1602
59. Vidal J, Morinigo R, Casamitjana R, Moize V, Gomis R 2003 Short-term effects of gastric bypass on circulating ghrelin levels. NAASO annual meeting. Obes Res 11(Suppl):A9
60. Copeland P, Davis P, Kaplan L 2003 Weight loss after gastric bypass is associated with decreased plasma gastric inhibitory polypeptide without a significant change in circulating ghrelin. NAASO annual meeting. Obes Res 11(Suppl):A17
61. Holdstock C, Engstrom BE, Obrvall M, Lind L, Sundbom M, Karlsson FA 2003 Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 88:3177-3183
62. Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E 1978 Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science 202:631-633
63. Rittmaster RS, Loriaux DL, Merriam GR 1987 Effect of continuous somatostatin and growth hormone-releasing hormone (GHRH) infusions on the subsequent growth hormone (GH) response to GHRH: evidence for somatotroph desensitization independent of GH pool depletion. Neuroendocrinology 45:118-122
64. Hanusch-Enserer U, Brabant G, Roden M 2003 Ghrelin concentrations in morbidly obese patients after adjustable gastric banding. N Engl J Med 348: 2159-2160
65. Adami GF, Cordera R, Marinari G, Lamerini G, Andraghetti G, Scopinaro N 2003 Plasma ghrelin concentration in the short-term following biliopancreatic diversion. Obes Surg 13:889-892
66. Cummings DE, Shannon MH 2003 Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab 88: 2999-3002
67. Williams DA, Cummings DE, Grill HJ, Kaplan JM 2003 Meal-related ghrelin suppression requires postgastric feedback. Endocrinology 144:2765-2767
68. Overduin J, Frayo RS, Cummings DE 2003 Role of the duodenum and macronutrient type in prandial suppression of ghrelin. NAASO annual meeting. Obes Res 11(Suppl):A21
69. Williams DL, Grill HJ, Cummings DE, Kaplan JM 2003 Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology 144:5184-5187
70. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D 2003 Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467-484; discussion 84-85
71. Sugerman HJ, Wolfe LG, Sica DA, Clore JN 2003 Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 237:751-756; discussion 757-758
72. Wittgrove AC, Clark GW 2000 Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up. Obes Surg 10:233-239
73. Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J 2000 Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 232:515-529
74. Long SD, O'Brien K, MacDonald Jr KG, Leggett-Frazier N, Swanson MS, Pories WJ, Caro JF 1994 Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care 17:372-375
75. Pender C, Goldfine ID, Tanner CJ, Pories WJ, MacDonald KG, Havel PJ, Houmard JA, Youngren JF 2004 Muscle insulin receptor concentrations in obese patients post bariatric surgery: relationship to hyperinsulinemia. Int J Obes Relat Metab Disord 28:363-369
76. Gray RE, Tanner CJ, Pories WJ, MacDonald KG, Houmard JA 2003 Effect of weight loss on muscle lipid content in morbidly obese subjects. Am J Physiol Endocrinol Metab 284:E726-E732
77. Houmard JA, Tanner CJ, Yu C, Cunningham PG, Pories WJ, MacDonald KG, Shulman GI 2002 Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes 51:2959-2963
78. Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, van der Lely AJ, Deghenghi R, Ghigo E 2001 Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86:5083-5086
79. Murata M, Okimura Y, Iida K, Matsumoto M, Sowa H, Kaji H, Kojima M, Kangawa K, Chihara K 2002 Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem 277:5667-5674
80. Svensson J, Lonn L, Jansson JO, Murphy G, Wyss D, Krupa D, Cerchio K, Polvino W, Gertz B, Boseaus I, Sjostrom L, Bengtsson BA 1998 Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J Clin Endocrinol Metab 83:362-369
81. Drucker DJ 2003 Glucagon-like peptide-1 and the islet β-cell: augmentation of cell proliferation and inhibition of apoptosis. Endocrinology 144:5145-5148
82. Zander M, Madsbad S, Madsen JL, Holst JJ 2002 Effect of 6-week course of glucagon-like peptide 1 on glycemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study. Lancet 359:824-830
83. Drucker DJ 2003 Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care 26:2929-2940
84. Naslund E, Gryback P, Backman L, Jacobsson H, Holst JJ, Theodorsson E, Hellstrom PM 1998 Distal small bowel hormones: correlation with fasting antroduodenal motility and gastric emptying. Dig Dis Sci 43:945-952
85. Naslund E, Backman L, Holst JJ, Theodorsson E, Hellstrom PM 1998 Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg 8:253-260
86. Naslund E, Gryback P, Hellstrom PM, Jacobsson H, Holst JJ, Theodorsson E, Backman L 1997 Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord 21:387-392
87. Sarson DL, Scopinaro N, Bloom SR 1981 Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. Int J Obes 5:471-480
88. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR 2003 Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349:941-948
89. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR 2002 Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:650-654
90. Andrews NJ, Irving MH 1992 Human gut hormone profiles in patients with short bowel syndrome. Dig Dis Sci 37:729-732
91. Greenway SE, Greenway FL, Klein S 2002 Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg 137:1109-1117
92. Rubino F, Gagner M 2002 Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 236:554-559
93. Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A 1998 Biliopancreatic diversion. World J Surg 22:936-946
94. Rubino F, Marescaux J 2004 Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 239:1-11
95. Sorensen TI, Lauritsen KB, Holst JJ, Stadil F, Andersen B 1983 Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio. Digestion 26:137-145
96. Meryn S, Stein D, Straus EW 1986 Pancreatic polypeptide, pancreatic glucagon, and enteroglucagon in morbid obesity and following gastric bypass operation. Int J Obes 10:37-42
97. Koopmans HS, Ferri GL, Sarson DL, Polak JM, Bloom SR 1984 The effects of ileal transposition and jejunoileal bypass on food intake and GI hormone levels in rats. Physiol Behav 33:601-609
98. Ueno T, Shibata C, Naito H, Jin XL, Funayama Y, Fukushima K, Matsuno S, Sasaki I 2002 Ileojejunal transposition delays gastric emptying and decreases fecal water content in dogs with total colectomy. Dis Colon Rectum 45:109-116
99. Ohtani N, Sasaki I, Naito H, Shibata C, Tsuchiya T, Matsuno S 1999 Effect of ileojejunal transposition of gastrointestinal motility, gastric emptying, and small intestinal transit in dogs. J Gastrointest Surg 3:516-523